GridAI Technologies GRDX
NASDAQ GRDX
$2.95 -0.07 (-2.16%)
As of: Sep 10, 2026 · 3:09 PM EDT

GridAI Technologies (GRDX) Dividends payables (2020 - 2026)

GridAI Technologies' (GRDX) quarterly Dividends payables came in at $1.8 million in Q2 2026, up 1008.29% on a YoY basis from $163428.0 in Q2 2025, and up 9.92% quarter-over-quarter from $1.6 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Dividends payables (2020 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Dividends payables for 7 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Dividends payables rose 1008.29% year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (up 1008.29% YoY), and the FY2025 full-year result was $1.6 million, up 25.73% from the prior year.
  • Dividends payables improved to $1.8 million in Q2 2026 per GRDX's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Dividends payables topped out at $1.8 million in Q2 2026 and bottomed at $66144.0 in Q1 2024.
  • Historically, Dividends payables has averaged $656299.8 across 5 years, with a median of $231047.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Dividends payables sank 55.58% in 2022, then surged 2004.26% in 2025.
  • Over 5 years, Dividends payables stood at $761488.0 in 2022, then soared by 40.46% to $1.1 million in 2023, then increased by 22.53% to $1.3 million in 2024, then rose by 25.73% to $1.6 million in 2025, then advanced by 9.92% to $1.8 million in 2026.
  • According to Business Quant data, Dividends payables over the past three periods registered $1.8 million, $1.6 million, and $1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Amgen 206.74 Bn 192.75 Bn 7.24 Bn -
2 Gilead Sciences 179.96 Bn 176.78 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 131.20 Bn 123.35 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.05 Bn 74.05 Bn 3.93 Bn -
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn -
6 Moderna 53.67 Bn 48.54 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.08 Bn 29.78 Bn 992.69 Mn -
8 Biogen 31.91 Bn 30.62 Bn 1.96 Bn -
9 Roivant Sciences 29.22 Bn 29.22 Bn 1.16 Mn -
10 GridAI Technologies 18.97 Mn 18.97 Mn -36,514.00 1.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.81 Mn
Dec 31, 2025 1.65 Mn
Sep 30, 2025 1.56 Mn
Jun 30, 2025 163,428.00
Mar 31, 2025 1.39 Mn
Dec 31, 2024 1.31 Mn
Sep 30, 2024 188,834.00
Jun 30, 2024 104,202.00
Mar 31, 2024 66,144.00
Dec 31, 2023 1.07 Mn
Sep 30, 2023 231,047.00
Jun 30, 2023 181,755.00
Mar 31, 2023 87,431.00
Dec 31, 2022 761,488.00
Sep 30, 2022 298,195.00
Jun 30, 2022 187,917.00
Mar 31, 2022 90,792.00
Dec 31, 2021 465,361.00
Sep 30, 2021 349,132.00
Jun 30, 2021 231,043.00